Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group

ZA can be safely combined with conventional chemotherapy with an MTD of 2.3 mg/m2 (max 4 mg) for patients with metastatic osteosarcoma.